Junshi Bio Updates Board Composition and Committee Leadership

Bulletin Express06-26

Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) released an updated list of directors and committee assignments dated 26 June 2026.

The Board now consists of 14 members: seven executive directors, two non-executive directors and five independent non-executive directors. Key positions are held by:

• Chairman and Legal Representative: Mr. Xiong Jun • Vice Chairman: Dr. Li Ning • Chief Executive Officer and General Manager: Dr. Zou Jianjun • Co-Chief Executive Officer: Mr. Li Cong

Five specialised committees remain in place, each led by an experienced director:

1. Audit Committee – chaired by independent non-executive director Mr. Li Zhongxian. 2. Nomination Committee – chaired by independent non-executive director Dr. Feng Xiaoyuan. 3. Remuneration and Appraisal Committee – chaired by Mr. Li Zhongxian. 4. Strategic and ESG Committee – chaired by Mr. Xiong Jun. 5. Compliance Committee – chaired by independent non-executive director Ms. Lu Kun.

Other directors serve as members across the committees to provide oversight on audit, governance, remuneration, strategy and compliance matters. The updated structure underscores Junshi Bio’s emphasis on balanced governance, independent oversight and strategic planning as the company continues to develop its biopharmaceutical portfolio.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1115841086?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-26 21:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115841086","market":"us","top_or_hot":-1,"title":"Junshi Bio Updates Board Composition and Committee Leadership","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) released an updated list of directors and committee assignments dated 26 June 2026.</p>\n<p>The Board now consists of 14 members: seven executive directors, two non-executive directors and five independent non-executive directors. Key positions are held by:</p>\n<p>• Chairman and Legal Representative: Mr. Xiong Jun  \n• Vice Chairman: Dr. Li Ning  \n• Chief Executive Officer and General Manager: Dr. Zou Jianjun  \n• Co-Chief Executive Officer: Mr. Li Cong</p>\n<p>Five specialised committees remain in place, each led by an experienced director:</p>\n<p>1. Audit Committee – chaired by independent non-executive director Mr. Li Zhongxian.  \n2. Nomination Committee – chaired by independent non-executive director Dr. Feng Xiaoyuan.  \n3. Remuneration and Appraisal Committee – chaired by Mr. Li Zhongxian.  \n4. Strategic and ESG Committee – chaired by Mr. Xiong Jun.  \n5. Compliance Committee – chaired by independent non-executive director Ms. Lu Kun.</p>\n<p>Other directors serve as members across the committees to provide oversight on audit, governance, remuneration, strategy and compliance matters. The updated structure underscores Junshi Bio’s emphasis on balanced governance, independent oversight and strategic planning as the company continues to develop its biopharmaceutical portfolio.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Bio Updates Board Composition and Committee Leadership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Bio Updates Board Composition and Committee Leadership\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-26 21:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) released an updated list of directors and committee assignments dated 26 June 2026.</p>\n<p>The Board now consists of 14 members: seven executive directors, two non-executive directors and five independent non-executive directors. Key positions are held by:</p>\n<p>• Chairman and Legal Representative: Mr. Xiong Jun  \n• Vice Chairman: Dr. Li Ning  \n• Chief Executive Officer and General Manager: Dr. Zou Jianjun  \n• Co-Chief Executive Officer: Mr. Li Cong</p>\n<p>Five specialised committees remain in place, each led by an experienced director:</p>\n<p>1. Audit Committee – chaired by independent non-executive director Mr. Li Zhongxian.  \n2. Nomination Committee – chaired by independent non-executive director Dr. Feng Xiaoyuan.  \n3. Remuneration and Appraisal Committee – chaired by Mr. Li Zhongxian.  \n4. Strategic and ESG Committee – chaired by Mr. Xiong Jun.  \n5. Compliance Committee – chaired by independent non-executive director Ms. Lu Kun.</p>\n<p>Other directors serve as members across the committees to provide oversight on audit, governance, remuneration, strategy and compliance matters. The updated structure underscores Junshi Bio’s emphasis on balanced governance, independent oversight and strategic planning as the company continues to develop its biopharmaceutical portfolio.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1115841086","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115841086","pubTimestamp":1782479099,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) released an updated list of directors and committee assignments dated 26 June 2026. The Board now consists of 14 members: seven executive directors,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物更新董事会组成及委员会领导层","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Bio) released an updated list of directors and committee assignments dated 26 June 2026.\nThe Board now consists of 14 members: seven executive directors, two non-executive directors and five independent non-executive directors. Key positions are held by:\n• Chairman and Legal Representative: Mr. Xiong Jun  \n• Vice Chairman: Dr. Li Ning  \n• Chief Executive Officer and General Manager: Dr. Zou Jianjun  \n• Co-Chief Executive Officer: Mr. Li Cong\nFive specialised committees remain in place, each led by an experienced director:\n1. Audit Committee – chaired by independent non-executive director Mr. Li Zhongxian.  \n2. Nomination Committee – chaired by independent non-executive director Dr. Feng Xiaoyuan.  \n3. Remuneration and Appraisal Committee – chaired by Mr. Li Zhongxian.  \n4. Strategic and ESG Committee – chaired by Mr. Xiong Jun.  \n5. Compliance Committee – chaired by independent non-executive director Ms. Lu Kun.\nOther directors serve as members across the committees to provide oversight on audit, governance, remuneration, strategy and compliance matters. The updated structure underscores Junshi Bio’s emphasis on balanced governance, independent oversight and strategic planning as the company continues to develop its biopharmaceutical portfolio.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115841086","isCrawlerRequest":true}